Interview with Francisco Billano, President, Interphil Laboratories
Interphil Laboratories has been active in the Philippines for a long time, having started in 1975 with the merger between Muller & Phipps. Can you give to our readers an…
Address: Canlubang Industrial Estate, Bo Pittland, 4025 Cabuyao, Laguna ,Philippines
Tel: +63 49 549-2345
Web: http://www.pharmaindustries.com/pi_home.html
Interphil Laboratories is a pharmaceutical contract manufacturer with a client-base of over 50 multinational companies, producing a wide range of healthcare products in many different forms, all in accordance with global standards. We have over 1,200 formulations currently in production in the largest, most advanced contract manufacturing facility in Asia.
Meeting the demands of our clients, Interphil Laboratories adheres to the highest standards of Quality Assurance. Our corporate policy of cGMP (current Good Manufacturing Practice) compliance is strictly enforced to ensure that the highest quality standards are applied in the preparation of only the safest, most efficacious products.
Interphil Laboratories has maintained a policy of not owning a proprietary brand in favor of safeguarding the confidentiality of clients’ manufacturing formulae.
Interphil Laboratories was born of the merger in 1978 between Pharma Industries Inc., a Zuellig-owned company established in the 1950’s, and Muller and Phipps, a US-owned company established in the 1940’s. The merged company was called Interphil and went public on the Philippines Stock Exchange in 1978.
Interphil Laboratories supports the supply chain of our clients with three core services: Product Development, Planning and Procurement and Contract Manufacturing. These services supply a competitive advantage for our clients by increasing available revenue streams, lowering costs and expanding a responsive production capacity.
Product development:
This service allows clients to develop line extensions and new pack sizes, and to receive assistance in the documentation licensing of existing formulations.
Planning & procurement:
This service offers clients customized materials, logistics planning and the benefits of group purchasing programs.
Toll manufacturing:
The multiple production facilities make possible the replication of manufacturing and packaging processes based on clients’ specifications.
Interphil Laboratories has been active in the Philippines for a long time, having started in 1975 with the merger between Muller & Phipps. Can you give to our readers an…
Gregorio (Greg) Navarro, Managing Partner & CEO of Deloitte Philippines, discusses the ASEAN region’s harmonization and what that means for the pharmaceutical industry, and further discusses the Philippines niche in…
Gregorio (Greg) Navarro, Managing Partner & CEO of Deloitte Philippines, discusses the ASEAN region’s harmonization and what that means for the pharmaceutical industry, and further discusses the Philippines niche in…
Pedro Miranda Jr., General Manager of Pacific Healthcare Philippines, talks about the decision to join Pacific Healthcare in the Philippines, how the company’s diversification strategy has evolved over the past…
Al Z. Castro, General Manager of IMS Health Philippines, speaks about the ongoing challenges of bringing about awareness and acceptance of generics medicine to the local population, how this will…
Ibrahim Monchito, Deputy Executive Director of the Department of Science and Technology ICT Office stresses the need to bring higher value to the HIM industry as a means to protect…
Reynaldo Dela Cruz Jr., President & General Manager of Lilly Philippines, gives his insight into the growing diabetes problem in the Philippines and what this means for Lilly Philippines as…
Reynaldo Dela Cruz Jr., President & General Manager of Lilly Philippines, gives his insight into the growing diabetes problem in the Philippines and what this means for Lilly Philippines as…
Thelma Tobias–Go, President of the Philippine Chamber of the Pharmaceutical Industry and Scheele Laboartories, and Ed Ocampo, COO and Vice President of Scheele Laboratories, discuss the implications of the changing…
Jason Carroll, General Manager of Janssen Philippines, discusses what it will take to put Janssen Philippines on the map as one of the largest, most reputable pharmaceutical companies in the…
Reynaldo Dela Cruz Jr., President & General Manager of Lilly Philippines, gives his insight into the growing diabetes problem in the Philippines and what this means for Lilly Philippines as…
Marcelina Itchon, President & CEO of Aspen Philippines, talks about what drives Aspen’s success, why the Philippines was the first choice from which to build an Asian division, and the…
Romeo Carbonel, President & CEO of RBC-MDC Philippines, and Minerva Carbonel, COO of RBC-MDC, speak about how RBC-MDC was founded, its path to success since its founding, and whether or…
See our Cookie Privacy Policy Here
